Pharma & Biotech

Investor attention is firmly fixed on BioNTech today as the German biopharmaceutical company prepares to release quarterly results that could...

Biopharmaceutical firm Ocugen stands at a pivotal crossroads, with its future trajectory largely dependent on advancements within its clinical development...

Shares of biotechnology firm MacroGenics are advancing in today's trading session, posting a notable gain of 4.1 percent. However, this...

Stereotaxis shares are encountering significant headwinds as the company approaches its quarterly earnings announcement. Technical indicators are flashing warning signs,...

Prelude Therapeutics Inc shares are demonstrating remarkable upward momentum, driven by two key factors: a substantial increase in analyst price...

BioTE stock enters a pivotal trading period as the healthcare services provider confronts mounting skepticism from market analysts. Trading at...

The biotechnology sector may have found its next rising star emerging from the diabetes treatment arena. While numerous pharmaceutical companies...

MiMedx Group Inc. is capturing significant market attention following a prominent upgrade to "Strong Buy" from Wall Street Zen. This...

Biogen finds itself in a curious position, delivering impressive third-quarter 2025 results that simultaneously impressed market analysts and disappointed investors....

The biotechnology sector has identified a compelling new prospect as Anixa Biosciences gains attention for its innovative approaches to cancer...